Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA NG

The biofungicide was registered for the management of anthracnose and target spot, two important soybean diseases.

Project goal is to expand yeast-based RNAi biopesticide platform technology applications to the many global agricultural pests living below ground.

Patent-pending fungal technology delivers up to 85% weed mortality and maintains 92% viability after 12 months in UK development studies.

State authority initiates public commenting phase following positive human health assessment, marking key step toward potential state registration.

Brazil and Paraguay submissions kick off a global registration launch for Promisin, with U.S. and EU filings to follow.

Seithor marks Seipasa’s entry into the herbicides market, pioneering a new product category that bolsters the company’s biocontrol portfolio.

Biologicals leaders explain how partnerships, trust, technical support, and strategic alignment drive growth in an increasingly competitive market.

Innovative “virus-like particle” platform technology significantly expands the agricultural application potential of Renaissance’s proprietary yeast-based RNA production and delivery systems.

Multi-strain microbial consortium suppresses Sclerotinia sclerotiorum and blocks new sclerotia formation, BTU plant physiologist reports in Vienna.